Amylyx Pharmaceuticals
AMLX
#6856
Rank
โ‚น39.73 B
Marketcap
โ‚น426.43
Share price
-6.53%
Change (1 day)
169.10%
Change (1 year)

Amylyx Pharmaceuticals (AMLX) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น15.02 Billion

According to Amylyx Pharmaceuticals's latest financial reports the company has โ‚น15.02 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Amylyx Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น15.14 B-51.02%
2023-12-31โ‚น30.91 B7.68%
2022-12-31โ‚น28.70 B301.3%
2021-12-31โ‚น7.15 B659.67%
2020-12-31โ‚น0.94 B330.87%
2019-12-31โ‚น0.21 B